Sio Gene Therapies
SIOX
$0.48
Share price
0.00%
Change (1 day)
16.59%
Change (1 year)
Sio Gene Therapies (SIOX) - Cash on Hand
Cash on Hand as of December 2022 : $46.12 M
According to Sio Gene Therapies's latest financial reports the company has $46.12 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Sio Gene Therapies - Cash on Hand chart (from 2015 to 2022)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-03-31 | $63.72 M | -46.44% |
| 2021-03-31 | $0.11 B | 47.35% |
| 2020-03-31 | $80.75 M | -24.53% |
| 2019-03-31 | $0.10 B | -30.67% |
| 2018-03-31 | $0.15 B | -27.4% |
| 2017-03-31 | $0.21 B | -23.05% |
| 2016-03-31 | $0.27 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $95.88 M | 107.86% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $20.82 M | -54.86% | 🇺🇸 USA |